The overall ratings of 3 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

Cumberland Pharmaceuticals Inc. (CPIX) declines this week from a C to a D. Cumberland Pharmaceuticals Inc. engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. The company also gets F’s in sales growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of CPIX stock.

Alimera Sciences, Inc. (ALIM) slips from a D to a F this week. Alimera Sciences, Inc. engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The company also gets F’s in free cash flow. For more information, get Portfolio Grader’s complete analysis of ALIM stock.

Pain Therapeutics, Inc. (PTIE) is having a tough week. The company’s rating falls from a C to a D. Pain Therapeutics, Inc. develops safer or more efficacious drugs for use in pain management, particularly in the area of opioid painkillers. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of PTIE stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.